1921
Volume 81, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Particular alleles of the gene have been correlated with increased risk of atrophic gastritis and gastric cancer in the populations of East Asia and Europe. No such data exist from Peru, a developing country with a population genotypically different from others studied and with a high prevalence of infection and gastric cancer. We conducted a case-control study comparing 334 hospitalized patients with atrophic gastritis or gastric cancer with 158 nonatrophic gastritis patients (controls). Conditional logistic regression analysis revealed that an increased risk of atrophic gastritis (odds ratio, 5.60) and gastric cancer (odds ratio, 2.36) was associated with the -511 C allele. Our study is the first to establish this allele as a risk for these conditions. Given the high prevalence of and recurrence rate after treatment, -511 single-nucleotide polymorphism analysis may identify those individuals who would benefit most from robust eradication efforts in Peru.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2009.08-0494
2009-11-01
2017-11-18
Loading full text...

Full text loading...

/deliver/fulltext/14761645/81/5/0810804.html?itemId=/content/journals/10.4269/ajtmh.2009.08-0494&mimeType=html&fmt=ahah

References

  1. Parkin DM, Pisani P, Ferlay J, 1999. Global cancer statistics. CA Cancer J Clin 49: 33–64.
  2. Stewart BW, Kleihues P, 2003. World Cancer Report. Stewart BW, Kleihues P, eds. Lyon: IARC Press, 12–19.
  3. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ, 2001. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784–789.
  4. Correa P, 1992. Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52: 6735–6740.
  5. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R, 1999. Helicobacter pylori virulence and genetic geography. Science 284: 1328–1333.
  6. Leung WK, Chan MC, To KF, Man EP, Ng EK, Chu ES, Lau JY, Lin SR, Sung JJ, 2006. H. pylori genotypes and cytokine gene polymorphisms influence the development of gastric intestinal metaplasia in a Chinese population. Am J Gastroenterol 101: 714–720.
  7. Rad R, Prinz C, Neu B, Neuhofer M, Zeitner M, Voland P, Becker I, Schepp W, Gerhard M, 2003. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 188: 272–281.
  8. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, Gerhard M, Prinz C, 2004. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53: 1082–1089.
  9. Kersulyte D, Mukhopadhyay AK, Velapatino B, Su W, Pan Z, Garcia C, Hernandez V, Valdez Y, Mistry RS, Gilman RH, Yuan Y, Gao H, Alarcon T, Lopez-Brea M, Balakrish NG, Chowdhury A, Datta S, Shirai M, Nakazawa T, Ally R, Segal I, Wong BC, Lam SK, Olfat FO, Boren T, Engstrand L, Torres O, Schneider R, Thomas JE, Czinn S, Berg DE, 2000. Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol 182: 3210–3218.
  10. Santos FR, Gerelsaikhan T, Munkhtuja B, Oyunsuren T, Epplen JT, Pena SD, 1996. Geographic differences in the allele frequencies of the human Y-linked tetranucleotide polymorphism DYS19. Hum Genet 97: 309–313.
  11. The Gastrointestinal Physiology Working Group of the Cayetano Heredia and the Johns Hopkins University, 1990. Helicobacter pylori and gastritis in Peruvian patients: relationship to socioeconomic level, age, and sex. Am J Gastroenterol 85: 819–823.
  12. The Gastrointestinal Physiology Working Group of the Cayetano Heredia and the Johns Hopkins University, 1992. Ecology of Helicobacter pylori in Peru: infection rates in coastal, high altitude, and jungle communities. Gut 33: 604–605.
  13. Soto G, Bautista CT, Roth DE, Gilman RH, Velapatino B, Ogura M, Dailide G, Razuri M, Meza R, Katz U, Monath TP, Berg DE, Taylor DN, The Gastrointestinal Physiology Working Group in Peru, 2003. Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. J Infect Dis 188: 1263–1275.
  14. Doglioni C, Turrin M, Macri E, Chiarelli C, Germana B, Barbareschi M, 1997. HpSS: a new silver staining method for Helicobacter pylori. J Clin Pathol 50: 461–464.
  15. Dixon MF, Genta RM, Yardley JH, Correa P, 1996. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20: 1161–1181.
  16. Chang YW, Jang JY, Kim NH, Lee JW, Lee HJ, Jung WW, Dong SH, Kim HJ, Kim BH, Lee JI, Chang R, 2005. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer 114: 465–471.
  17. Yamada S, Matsuhisa T, Makonkawkeyoon L, Chaidatch S, Kato S, Matsukura N, 2006. Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in Thais. J Gastroenterol 41: 1169–1177.
  18. Yang J, Hu Z, Xu Y, Shen J, Niu J, Hu X, Guo J, Wei Q, Wang X, Shen H, 2004. Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett 215: 191–198.
  19. Ikehara SK, Ikehara Y, Matsuo K, Hirose K, Niwa T, Ito H, Ito S, Kodera Y, Yamamura Y, Nakanishi H, Tatematsu M, Tajima K, 2006. A polymorphism of C-to-T substitution at -31 IL1B is associated with the risk of advanced gastric adenocarcinoma in a Japanese population. J Hum Genet 51: 927–933.
  20. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, Matsuhisa T, Yamada N, 2003. Genetic differences in interleukin-1 betapolymorphisms among four Asian populations: an analysis of the Asian paradox between H. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res 22: 47–55.
  21. El Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF Jr, Chow WH, 2003. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124: 1193–1201.
  22. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doorn LJ, Carneiro F, Sobrinho-Simoes M, 2002. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 94: 1680–1687.
  23. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, Sobrinho-Simoes M, 2001. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121: 823–829.
  24. Ruzzo A, Graziano F, Pizzagalli F, Santini D, Battistelli V, Panunzi S, Canestrari E, Catalano V, Humar B, Ficarelli R, Bearzi I, Cascinu S, Naldi N, Testa E, Magnani M, 2005. Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Ann Oncol 16: 887–892.
  25. Camargo MC, Mera R, Correa P, Peek RM Jr, Fontham ET, Goodman KJ, Piazuelo MB, Sicinschi L, Zabaleta J, Schneider BG, 2006. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15: 1674–1687.
  26. Kamangar F, Cheng C, Abnet CC, Rabkin CS, 2006. Interleukin-1B polymorphisms and gastric cancer risk-a meta-analysis. Cancer Epidemiol Biomarkers Prev 15: 1920–1928.
  27. Vincenzi B, Patti G, Galluzzo S, Pantano F, Venditti O, Santini D, Ruzzo A, Schiavon G, Caraglia M, Marra M, Graziano F, Tonini G, 2008. Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis. Oncol Rep 20: 1213–1220.
  28. Wang P, Xia HH, Zhang JY, Dai LP, Xu XQ, Wang KJ, 2007. Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int J Cancer 120: 552–562.
  29. Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, Ng M, Sung JJ, 2003. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 52: 1684–1689.
  30. Bardhan PK, 1997. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis 25: 973–978.
  31. The Gastrointestinal Physiology Working Group of the Cayetano Heredia and the Johns Hopkins University, 1986. Rapid identification of pyloric Campylobacter in Peruvians with gastritis. Dig Dis Sci 31: 1089–1094.
  32. Recavarren-Arce S, Leon-Barua R, Rodriguez C, Cok J, Berendson R, Gilman RH, 1995. Helicobacter pylori-associated chronic gastritis in Peruvian adolescents is very common and severe. J Clin Gastroenterol 20: 335–337.
  33. Recavarren-Arce S, Ramirez-Ramos A, Gilman RH, Chinga-Alayo E, Watanabe-Yamamoto J, Rodriguez-Ulloa C, Miyagui J, Passaro DJ, Eza D, 2005. Severe gastritis in the Peruvian Andes. Histopathology 46: 374–379.
  34. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, Yamaoka Y, 2002. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 123: 1793–1803.
  35. Xuan J, Deguchi R, Watanabe S, Ozawa H, Urano T, Ogawa Y, Fukuda R, Kijima H, Koga Y, Takagi A, 2005. Relationship between IL-1beta gene polymorphism and gastric mucosal IL-1beta levels in patients with Helicobacter pylori infection. J Gastroenterol 40: 796–801.
  36. Chakravorty M, Ghosh A, Choudhury A, Santra A, Hembrum J, Roychoudhury S, 2006. Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer. Hum Mutat 27: 411–419.
  37. Danon SJ, O’Rourke JL, Moss ND, Lee A, 1995. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology 108: 1386–1395.
  38. Fukui H, Franceschi F, Penland RL, Sakai T, Sepulveda AR, Fujimori T, Terano A, Chiba T, Genta RM, 2003. Effects of Helicobacter pylori infection on the link between regenerating gene expression and serum gastrin levels in Mongolian gerbils. Lab Invest 83: 1777–1786.
  39. Bayerdorffer E, Lehn N, Hatz R, Mannes GA, Oertel H, Sauerbruch T, Stolte M, 1992. Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 102: 1575–1582.
  40. de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE, 1991. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209–1220.
  41. Garza-Gonzalez E, Hold G, Perez-Perez GI, Bosques-Padilla FJ, Tijerina-Menchaca R, Maldonado-Garza HJ, el Omar E, 2003. Role of polymorphism of certain cytokines in gastric cancer in Mexico. Preliminary results. Rev Gastroenterol Mex 68: 107–112.
  42. Garcia-Gonzalez MA, Lanas A, Santolaria S, Crusius JB, Serrano MT, Pena AS, 2001. The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer. Clin Exp Immunol 125: 368–375.
  43. Garcia-Gonzalez MA, Lanas A, Savelkoul PH, Santolaria S, Benito R, Crusius JB, Pena AS, 2003. Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease. Clin Exp Immunol 134: 525–531.
  44. Santtila S, Savinainen K, Hurme M, 1998. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47: 195–198.
  45. El Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS, 2000. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398–402.
  46. Perez-Perez GI, Garza-Gonzalez E, Portal C, Olivares AZ, 2005. Role of cytokine polymorphisms in the risk of distal gastric cancer development. Cancer Epidemiol Biomarkers Prev 14: 1869–1873.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2009.08-0494
Loading
/content/journals/10.4269/ajtmh.2009.08-0494
Loading

Data & Media loading...

  • Received : 24 Sep 2008
  • Accepted : 14 Jul 2009

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error